I’ve always been interested in the business models and competitive strategies of the biopharma sector. And also in the legal and public policy underpinnings of the technology sector. Sharing my enthusiasm for these topics, I’ve taught policy and law classes at the George Washington University Law School, The Johns Hopkins University, The University of Maryland General Honors Program and the FAES Graduate School at the National Institutes of Health.
For the Fall 2015 semester, I’ll be co-teaching Innovation Management for the Johns Hopkins University’s graduate program in biotechnology along with Jill Sorensen. In previous semesters, I’ve also taught Technology Transfer and Commercialization, with Jill, and Legal Aspects of Biotechnology as an on-line class. In 2011, I taught “Strategic Planning for the Biotech Enterprise” as an on-line coursem.
And I’ve published a number of articles, spoken frequently at conferences and testified before Congress about IP and technology transfer matters. My favorites of these include:
“Inspirations for BioPharma IP Strategy,” for the Chicago Chapter, Licensing Executives Society, Chicago, IL, May 22, 2012.
Co-authored amicus brief to the U.S. Supreme Court for the prevailing party in J.E.M. Ag Supply, Inc. v. Pioneer Hi-Bred Int’l, Inc., 534 U.S. 124 (2001)
“Genome research: fulfilling the public’s expectations for knowledge and commercialization,” Science 14 August 1992: 908-914
“Controlling the Applications of Biotechnology: A Critical Analysis of the Proposed Moratorium on Animal Patenting,” 1 Harvard Journal of Law and Technology 1, May 1988
“Biotechnology as an intellectual property,” Science 27 April 1984: 357-363
And look for the book I’m writing with Dan Passeri of Curis, Inc., entitled Law and Business Strategies for the Life Science Enterprise, Oxford University Press (forthcoming 2013).